Skip to main content
. 2005 Aug 21;11(31):4833–4837. doi: 10.3748/wjg.v11.i31.4833

Table 4.

Number of subjects with or without haplotype NAT2*7B

NAT2*7B UC (n = 95, %) CD (n = 60, %) Control (n = 200, %)
Presence 19 (20.0) 17 (28.3) 32 (16.0)
Absence 76 (80.0) 43 (71.7) 168 (84.0)

CD patients vs controls: P = 0.032, OR = 2.076.